Sodium salicylate
CAS No. 54-21-7
Sodium salicylate ( Sodium salicylate; Kerasalicyl; Kerosal; Magsalyl )
Catalog No. M14942 CAS No. 54-21-7
Sodium salicylate is a metabolite of acetylsalicylic acid, and functions by inhibiting NF-kB and reduces oxidative stress.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 41 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSodium salicylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium salicylate is a metabolite of acetylsalicylic acid, and functions by inhibiting NF-kB and reduces oxidative stress.
-
DescriptionSodium salicylate is a metabolite of acetylsalicylic acid, and functions by inhibiting NF-kB and reduces oxidative stress.
-
SynonymsSodium salicylate; Kerasalicyl; Kerosal; Magsalyl
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1; COX-3; NF-κB
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number54-21-7
-
Formula Weight160.11
-
Molecular FormulaC7H5NaO3
-
Purity>98%(HPLC)
-
SolubilityWater: 32 mg/mL (198.62 mM); DMSO: 32 mg/mL (198.62 mM)
-
SMILESO=C([O-])C1=CC=CC=C1O.[Na+]
-
Chemical NameBenzoic acid, 2-hydroxy-, monosodium salt
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kopp E, et al. Science, 1994, 265(5174), 956-959.
molnova catalog
related products
-
Fenoprofen calcium
An anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to ASPIRIN, but causes less gastrointestinal bleeding.
-
Hirsutanonol
Hirsutanonol is a secondary metabolite from the bark of Alnus glutinosa. Hirsutanonol has potent antioxidant and free radical scavenging activities and exhibits an inhibition effect on mitochondrial lipid peroxidation. Hirsutanonol can be used for studies
-
Dexketoprofen tromet...
Dexketoprofen trometamol is a modified non-selective COX inhibitor with a rapid onset of action that is available as both oral and parenteral formulations.